Dermovix
- Product NDC
- 69440-009
- Requested package NDC
- 69440-009-15
- 11-digit product format
- 694400009
- Labeler code
- 69440
- Product ID
- 69440-009_8546bcf1-481e-4142-87f3-0c95fb3927b1
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Allantoin,Petrolatum
- Dosage form
- PATCH
- Route
- TOPICAL
- Labeler
- Binger Consulting Corporation
- Application
- part347
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2015-01-01
- Marketing end
- 0000-00-00
- Substance
- ALLANTOIN; PETROLATUM
- Active strength
- 2 g/100g; g/100g
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 69440-009 | 69440-009-15 | I | Inactivated by FDA | 2026-10-16 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 69440-009 | 69440-009-15 | I | Inactivated by FDA | excluded / ndc_excluded.zip | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 69440-009 | 69440-009-15 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 9bebd1f3094a… | 5416666fcb17… | |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 69440-009 | 69440-009-15 | E | Excluded after deficient or non-compliant submission was not corrected | excluded / ndc_excluded.zip | 110d247fa046… | a55b01930146… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69440-009-15 | 2021-10-21 | C162847 | 48780-1 | 9d75b9d0-19cf-f424-e053-dadaa90a57ce | Dermovix |
| 69440-009-15 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-19cf-f424-e053-dadaa90a57ce | Dermovix |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69440-009-15 | Dermovix | 15 in 1 BOX | PATCH | 15 | 4 | |
| 69440-009-15 | Dermovix | 100 g in 1 PATCH | PATCH | 100 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69440-009-15 | EA - Each | 69440-009 | f2fd9e41-9496-445c-949b-3129d83f8b0e | 1 | 2015-10-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ALLANTOIN | ACTIVE INGREDIENT | 344S277G0Z | DERMOVIX (ALLANTOIN,PETROLATUM) PATCH [BINGER CONSULTING CORPORATION] | 2 | |
| PETROLATUM | ACTIVE INGREDIENT | 4T6H12BN9U | DERMOVIX (ALLANTOIN,PETROLATUM) PATCH [BINGER CONSULTING CORPORATION] | 2 | |
| ALLANTOIN | ACTIVE MOIETY | 344S277G0Z | DERMOVIX (ALLANTOIN,PETROLATUM) PATCH [BINGER CONSULTING CORPORATION] | 2 | |
| PETROLATUM | ACTIVE MOIETY | 4T6H12BN9U | DERMOVIX (ALLANTOIN,PETROLATUM) PATCH [BINGER CONSULTING CORPORATION] | 2 | |
| .ALPHA.-TOCOPHEROL | INACTIVE INGREDIENT | H4N855PNZ1 | DERMOVIX (ALLANTOIN,PETROLATUM) PATCH [BINGER CONSULTING CORPORATION] | 2 | |
| LIDOCAINE | INACTIVE INGREDIENT | 98PI200987 | DERMOVIX (ALLANTOIN,PETROLATUM) PATCH [BINGER CONSULTING CORPORATION] | 2 | |
| ONION | INACTIVE INGREDIENT | 492225Q21H | DERMOVIX (ALLANTOIN,PETROLATUM) PATCH [BINGER CONSULTING CORPORATION] | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1648752 | petrolatum 30 % Medicated Patch | PSN | 33139e68-3714-41e8-a3a7-24f28e8b409b | 4 |
| 1648752 | petrolatum 0.3 MG/MG Medicated Patch | SCD | 33139e68-3714-41e8-a3a7-24f28e8b409b | 4 |
| 1648752 | petrolatum 30 % Medicated Patch | SY | 33139e68-3714-41e8-a3a7-24f28e8b409b | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 69440-009-15 | 69440000915 | 15 PATCH in 1 BOX (69440-009-15) > 100 g in 1 PATCH | 15 patch | 2015-01-01 | 0000-00-00 | No | No | Current |